Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save this grant
Crystal ball icon
Predicted Deadline
The next cycle for this opportunity is predicted based on past data. If you save this grant, we’ll notify you if there are any changes.

Next predicted deadline: Oct 21, 2023 (Letter of inquiry)

Later predicted deadlines: Oct 21, 2023 (Letter of inquiry), Nov 21, 2023 (Full proposal), Nov 21, 2023 (Full proposal), Nov 21, 2023 (Letter of inquiry), Dec 21, 2023 (Full proposal), Jan 21, 2024 (Letter of inquiry), Feb 21, 2024 (Full proposal), Mar 18, 2024 (Letter of inquiry), Apr 18, 2024 (Full proposal), Jun 22, 2024 (Letter of inquiry), Jul 22, 2024 (Full proposal), Oct 21, 2024 (Letter of inquiry), Nov 21, 2024 (Full proposal)

Grant amount: Up to US $1,050,000

Fields of work: Cardiovascular Diseases & Systems Hematological Systems Respiratory Diseases & Systems Sleep

Applicant type: Government Entity, Nonprofit, For-Profit Business, Indigenous Group

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico Show all

Overview:

NOTE: All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates by 5:00 PM local time of applicant organization:

  • November 21, 2022
  • February 21, 2023 
  • July 21, 2023 
  • November 21, 2023 
  • February 21, 2024 
  • July 22, 2024 
  • November 21, 2024

All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates by 5:00 PM local time of applicant organization:

  • December 21, 2022
  • April 18, 2023
  • August 18, 2023 
  • December 21, 2023
  • April 18, 2024 
  • August 19, 2024
  • December 20, 2024

This Catalyze Product Definition Funding Opportunity Announcement (FOA) will provide the early stage translational support needed to identify and characterize potential therapeutic candidates to treat heart, lung, blood, and sleep diseases and disorders. This FOA is part of a suite of Catalyze innovation grants to advance projects to the point where they can meet the entry criteria for the NHLBI Catalyze Preclinical program or attract independent development support from other federal or private partners for preclinical optimization and development of therapeutic agents.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

Forecasted Funding Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih) help icon

This page was last reviewed May 09, 2023 and last updated May 09, 2023